3D Cell Culture Market - Global Forecast to 2030
商品番号 : SMB-15965
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年10月 |
| ページ数 | 323 |
| 図表数 | 409 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
三次元細胞培養市場 – 製品（スキャフォールド[ハイドロゲル、固体スキャフォールド]、スキャフォールドフリー[低接着プレート、マイクロ流体、バイオプリント]）、用途（がん、幹細胞研究、組織工学）、トレンド、エンドユーザー、地域別 – 2030年までの世界予測
世界の三次元細胞培養（3D細胞培養）市場は、2024年の11億8,000万米ドルから2030年には22億6,000万米ドルに達し、予測期間中は年平均成長率（CAGR）11.7%で成長すると予測されています。3D細胞培養の導入拡大や3D細胞培養研究への資金提供の増加といった要因が市場の成長を牽引しています。
本調査レポートは、三次元細胞培養（3D細胞培養）市場を製品別（スキャフォールドベース3D細胞培養、スキャフォールドフリー3D細胞培養、マイクロ流体ベース3D細胞培養、磁性およびバイオプリント3D細胞培養）、用途別（がんおよび幹細胞研究、創薬および毒性試験、組織工学および再生医療）、エンドユーザー別（製薬およびバイオテクノロジー企業、研究機関、化粧品業界、その他のエンドユーザー）、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカ）に分類しています。レポートは、3D細胞培養市場の成長に影響を与える推進要因、課題、機会、制約など、主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、サービスポートフォリオ、コラボレーション、パートナーシップ、拡張、契約、買収などの主要戦略、そして3D細胞培養市場に関連する最近の動向に関する洞察を提供しています。このレポートでは、3D 細胞培養市場のエコシステムにおけるトップ プレーヤーと今後の新興企業の競合分析を取り上げています。
本レポートは、三次元細胞培養（3D細胞培養）市場の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーを徹底的に分析し、事業概要、ソリューション、サービス、主要戦略、新製品の発売、買収、3D細胞培養市場に関連する最近の動向に関する洞察を提供しています。本レポートは、3D細胞培養市場エコシステムにおける新興企業の競合分析も網羅しています。
本レポートは、三次元細胞培養（3D細胞培養）市場全体とそのサブセグメントの収益数値に最も近い概算値を提供することで、市場リーダー／新規参入企業を支援します。また、ステークホルダーが競争環境をより深く理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供することを可能にします。
The global 3D cell culture market is projected to reach USD 2.26 billion by 2030 from USD 1.18 billion in 2024, at a CAGR of 11.7% during the forecast period. Factors such as increased adoption of 3D cell culture and a rise in funding for 3D cell culture research drive market growth.
The scaffold-based 3D cell culture segment accounted for the highest market share in the product market.
Based on the product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2024. Hydrogels/ECM analogs have emerged as the key contributor to segment growth. Increased demand for hydrogels is raising the focus of key market players on the development and launch of new products in the market. It is also biocompatible and non-toxic, making it ideal for use in research and drug development.
The cancer and stem cell research segment accounted for the largest share of the application market in 2024.
Based on the application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share in 2024. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment.
The Asia Pacific region is likely to be the fastest-growing regional market.
The 3D cell culture market is segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to be the fastest-growing regional segment during the forecast period. Growth in this market is attributed to the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries. The markets for biologics such as antibodies and protein-based drugs are also on the rise in the Asia Pacific region. Biotechnology-based drugs are anticipated to be one of the key drivers for the research industry due to increased research and government funds provided for these drugs. Global pharmaceutical firms are increasingly moving to Asia to tap into its thriving market and lower their production costs by shifting manufacturing to the region.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Tier 1- 25%, Tier 2- 35%, and Tier 3- 40%
- By Designation: C-level Executives- 55%, Directors- 20%, and Others- 25%
- By Region: North America- 45%, Europe- 20%, the Asia Pacific- 20%, Latin America- 10%, the Middle East- 3%, and Africa- 2%
The top players in the global 3D cell culture market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Tecan Trading AG (Switzerland), Avantor, REPROCELL Inc. (Japan), 3D Biotek LLC. (US), S-BIO, Vaupell Holdings Inc. (US), Advanced BioMatrix Inc. (US), UPM Biomedicals (Finland), SYNTHECON, INCORPORATED (US), Emulate, Inc. (US), CN Bio Innovations Ltd. (UK), Kirkstall Ltd. (UK), Lena Biosciences (US), TissUse GmbH (Germany), Cellendes GmbH (Germany), Greiner Bio-one International GmbH (Germany), AMSBIO (UK), MIMETAS B.V.(Netherlands), and Promocell GmbH (Germany).
Research Coverage
This research report categorizes the 3D cell culture market by product (scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures), application (cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine), end user (pharmaceutical & biotechnology companies, research institutes, cosmetics industry, and other end users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the 3D cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the 3D cell culture market. This report covers a competitive analysis of top players and upcoming startups in the 3D cell culture market ecosystem.
The report’s scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the 3D cell culture market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product launches, acquisitions, and recent developments associated with the 3D cell culture market. This report covers the competitive analysis of upcoming startups in the 3D cell culture market ecosystem.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (high focus on developing alternatives to animal testing, increasing adoption of personalized medicine, increased government support and funding, rising academia-research collaborations), restraints (high cost of implementing 3D cell culture technologies, lack of widely accepted or single standardization in 3D cell culture), opportunities (emergence of microfluidic based 3D cell culture), and challenges (lack of consistency in 3D cell culture products, high dependency on plastic waste disposals and consumables) influencing the growth of 3D cell culture market.
- Product Development/Innovation: Detailed insights on newly launched products of the 3D cell culture market
- Market Development: Comprehensive information about lucrative markets – the report analyses the 3D cell culture market across varied regions.
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D cell culture market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US), among others
Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 MARKET SCOPE 33
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 33
1.3.2 INCLUSIONS AND EXCLUSIONS 33
1.3.3 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF STRATEGIC CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Key sources of secondary data 37
2.1.1.2 Key objectives of secondary research 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Breakdown of primaries 38
2.1.2.2 Key objectives of primary research 39
2.2 MARKET SIZE ESTIMATION 39
2.2.1 GLOBAL MARKET SIZE ESTIMATION 39
2.2.1.1 Revenue share analysis (bottom-up approach) 40
2.2.1.2 Secondary data 41
2.2.1.3 Primary interviews and MnM repository analysis 42
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 42
2.2.3 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH) 43
2.3 GROWTH RATE PROJECTION 44
2.4 DATA TRIANGULATION 46
2.5 RESEARCH ASSUMPTIONS 47
2.6 RESEARCH LIMITATIONS 48
2.7 RISK ANALYSIS 48
3 EXECUTIVE SUMMARY 49
3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 49
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS 51
3.3 DISRUPTIVE TRENDS SHAPING MARKET 51
3.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 51
3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 52
4 PREMIUM INSIGHTS 53
4.1 UNMET NEEDS AND WHITE SPACES 53
4.2 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53
4.3 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS 53
4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 54
4.5 VC/PRIVATE EQUITY INVESTMENT TRENDS AND STARTUP LANDSCAPE 54
4.6 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 54
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
5.2.1 DRIVERS 57
5.2.1.1 High focus on developing alternatives to animal testing 57
5.2.1.2 Growing shift toward personalized medicine 58
5.2.1.3 Integration of microphysiological systems and organ-on-chip platforms 59
5.2.2 RESTRAINTS 60
5.2.2.1 High costs of implementing 3D cell culture technologies 60
5.2.2.2 Absence of widely accepted or unified standards for experimental protocols 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 High growth opportunities and booming biopharmaceutical sector in emerging economies 61
5.2.4 CHALLENGES 61
5.2.4.1 Lack of consistency in scaffold-based 3D cell culture products 61
5.2.4.2 High dependence on plastic waste disposals and consumables 62
5.3 TECHNOLOGY ANALYSIS 63
5.3.1 KEY TECHNOLOGIES 63
5.3.1.1 Microfluidics 63
5.3.1.2 Bioprinting 64
5.3.1.3 Organ-on-chip 64
5.3.2 COMPLEMENTARY TECHNOLOGIES 64
5.3.2.1 High-content imaging and automated microscopy 64
5.3.2.2 High-throughput screening platforms 65
5.3.3 ADJACENT TECHNOLOGIES 65
5.3.3.1 Magnetic levitation 65
5.3.3.2 Microfabrication 65
5.4 TRADE ANALYSIS 66
5.4.1 IMPORT DATA 66
5.4.2 EXPORT DATA 67
5.5 REGULATORY LANDSCAPE 69
5.5.1 REGULATORY FRAMEWORK 69
5.5.1.1 North America 69
5.5.1.2 Europe 69
5.5.1.3 Asia Pacific 70
5.5.1.4 Latin America 71
5.5.1.5 Middle East & Africa 71
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
5.6 PORTER’S FIVE FORCES ANALYSIS 75
5.6.1 BARGAINING POWER OF SUPPLIERS 76
5.6.2 BARGAINING POWER OF BUYERS 76
5.6.3 THREAT OF NEW ENTRANTS 76
5.6.4 THREAT OF SUBSTITUTES 76
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 77
5.7 IMPACT OF AI/GENERATIVE AI ON 3D CELL CULTURE MARKET 77
5.7.1 INTRODUCTION 77
5.7.2 MARKET POTENTIAL OF AI IN 3D CELL CULTURE APPLICATIONS 77
5.7.3 AI USE CASES 78
5.7.4 KEY COMPANIES IMPLEMENTING AI 78
5.7.5 FUTURE OF GENERATIVE AI IN 3D CELL CULTURE ECOSYSTEM 79
5.8 IMPACT OF 2025 US TARIFF ON 3D CELL CULTURE MARKET 79
5.8.1 INTRODUCTION 79
5.8.2 KEY TARIFF RATES 80
5.8.3 PRICE IMPACT ANALYSIS 81
5.8.4 IMPACT ON COUNTRY/REGION 81
5.8.4.1 US 81
5.8.4.2 Europe 82
5.8.4.3 Asia Pacific 82
5.8.5 IMPACT ON END-USE INDUSTRIES 83
5.8.5.1 Pharmaceutical and biotech companies 83
5.8.5.2 Hospitals and diagnostic laboratories 83
5.8.5.3 Academic and research institutes 84
5.8.5.4 Contract research organizations & contract development and manufacturing organizations 84
6 INDUSTRY TRENDS 85
6.1 PRICING ANALYSIS 85
6.1.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 85
6.1.2 AVERAGE SELLING PRICE TREND, BY REGION 88
6.2 PATENT ANALYSIS 90
6.2.1 METHODOLOGY 90
6.2.2 NUMBER OF PATENTS FILED 91
6.2.3 LIST OF KEY PATENTS 92
6.3 KEY CONFERENCES AND EVENTS, 2025–2026 93
6.4 INVESTMENT AND FUNDING SCENARIO 94
6.5 VALUE CHAIN ANALYSIS 95
6.6 ECOSYSTEM ANALYSIS 97
6.7 KEY STAKEHOLDERS AND BUYING CRITERIA 99
6.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
6.7.2 KEY BUYING CRITERIA 100
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 101
7 3D CELL CULTURE MARKET, BY TYPE 103
7.1 INTRODUCTION 104
7.2 SCAFFOLD-BASED 3D CELL CULTURES 104
7.2.1 HYDROGELS/ECM ANALOGS 108
7.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell culture market during forecast period 108
7.2.2 SOLID SCAFFOLDS 111
7.2.2.1 Growing adoption of solid scaffolds in regenerative medicine and preclinical in vitro testing to boost market 111
7.2.3 MICROPATTERNED SURFACES 115
7.2.3.1 Ability of micropatterned surfaces to enhance expression of enzyme levels and drug reactivity to drive growth 115
7.3 SCAFFOLD-FREE 3D CELL CULTURES 118
7.3.1 LOW-ATTACHMENT PLATES 122
7.3.1.1 Low-attachment plates to grow at highest rate in scaffold-free 3D cell cultures market 122
7.3.2 HANGING DROP PLATES 125
7.3.2.1 Growing use of hanging drop plates in stem cell differentiation and cytotoxicity research to propel growth 125
7.3.3 3D BIOREACTORS 129
7.3.3.1 Wide usage of 3D bioreactors in mass production of cells to support market growth 129
7.4 MICROFLUIDICS-BASED 3D CELL CULTURES 132
7.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE IN 3D CELL CULTURE MARKET DURING FORECAST PERIOD 132
7.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES 135
7.5.1 GROWING USE OF BIOPRINTING TECHNOLOGIES IN CANCER MODEL CREATION TO BOOST MARKET 135
8 3D CELL CULTURE MARKET, BY APPLICATION 139
8.1 INTRODUCTION 140
8.2 CANCER & STEM CELL RESEARCH 140
8.2.1 INCREASING DEMAND FOR PATIENT-DERIVED, AUTOMATED 3D ORGANOID SYSTEMS TO PROPEL MARKET 140
8.3 DRUG DISCOVERY & TOXICOLOGY TESTING 144
8.3.1 REGULATORY DEMAND AND TECHNOLOGICAL MATURATION OF PREDICTIVE 3D TOXICOLOGY MODELS TO DRIVE MARKET GROWTH 144
8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 147
8.4.1 ADVANCEMENTS IN BIOMATERIAL INNOVATION AND SCAFFOLD CUSTOMIZATION TO BOOST MARKET 147
8.5 3D CELL CULTURE MARKET, BY MODEL TYPE 151
9 3D CELL CULTURE MARKET, BY END USER 152
9.1 INTRODUCTION 153
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 153
9.2.1 GROWING INTEGRATION OF 3D MODELS BY PHARMA AND BIOTECH COMPANIES TO DRIVE MARKET GROWTH 153
9.3 RESEARCH INSTITUTES 157
9.3.1 RESEARCH GRANTS FROM GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS TO AUGMENT MARKET 157
9.4 COSMETICS INDUSTRY 161
9.4.1 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET 161
9.5 OTHER END USERS 164
10 3D CELL CULTURE MARKET, BY REGION 168
10.1 INTRODUCTION 169
10.2 NORTH AMERICA 169
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 170
10.2.2 US 174
10.2.2.1 Product launches and capacity expansions to drive market growth 174
10.2.3 CANADA 176
10.2.3.1 Advancements in tissue therapeutics and regenerative medicine to boost market 176
10.3 EUROPE 179
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 179
10.3.2 GERMANY 182
10.3.2.1 Strategic acquisitions to fuel market growth 182
10.3.3 UK 185
10.3.3.1 Growing government funding and initiatives to propel market growth 185
10.3.4 FRANCE 187
10.3.4.1 Strategic collaborations to propel market growth 187
10.3.5 ITALY 190
10.3.5.1 Strong government support to enhance R&D activities 190
10.3.6 SPAIN 192
10.3.6.1 Strategic R&D investments and collaborative frameworks to drive market 192
10.3.7 REST OF EUROPE 195
10.4 ASIA PACIFIC 197
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 197
10.4.2 CHINA 201
10.4.2.1 Rising pharmaceutical R&D and investments to drive market growth 201
10.4.3 JAPAN 204
10.4.3.1 Strategic collaborations and technological advancements to augment market 204
10.4.4 INDIA 207
10.4.4.1 Strategic collaborations and infrastructure development to support market 207
10.4.5 SOUTH KOREA 209
10.4.5.1 Strategic investments and collaborations to propel market growth 209
10.4.6 AUSTRALIA 212
10.4.6.1 Advancements in 3D cell culture technologies to propel market 212
10.4.7 REST OF ASIA PACIFIC 214
10.5 LATIN AMERICA 217
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 218
10.5.2 BRAZIL 221
10.5.2.1 Rising prevalence of cancer and therapeutic development to support market 221
10.5.3 MEXICO 224
10.5.3.1 Growth in biopharmaceutical market to spur 3D cell culture demand 224
10.5.4 REST OF LATIN AMERICA 226
10.6 MIDDLE EAST 229
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 229
10.6.2 GCC COUNTRIES 232
10.6.2.1 Saudi Arabia 235
10.6.2.1.1 Strategic healthcare initiatives to drive market 235
10.6.2.2 UAE 238
10.6.2.2.1 Developments in healthcare infrastructure and growing government initiatives to drive market 238
10.6.2.3 Rest of GCC Countries 240
10.6.3 REST OF MIDDLE EAST 243
10.7 AFRICA 246
10.7.1 STRATEGIC COLLABORATIONS AND HEALTH INITIATIVES TO FUEL MARKET GROWTH 246
10.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 246
11 COMPETITIVE LANDSCAPE 250
11.1 INTRODUCTION 250
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 250
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN 3D CELL CULTURE MARKET 251
11.3 REVENUE ANALYSIS, 2020−2024 253
11.4 MARKET SHARE ANALYSIS, 2024 254
11.5 COMPANY VALUATION AND FINANCIAL METRICS 256
11.5.1 COMPANY VALUATION 256
11.5.2 FINANCIAL METRICS 257
11.6 BRAND/PRODUCT COMPARISON 257
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 258
11.7.1 STARS 258
11.7.2 EMERGING LEADERS 258
11.7.3 PERVASIVE PLAYERS 258
11.7.4 PARTICIPANTS 258
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 260
11.7.5.1 Company footprint 260
11.7.5.2 Region footprint 261
11.7.5.3 Product footprint 262
11.7.5.4 Application footprint 262
11.7.5.5 End-user footprint 263
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 264
11.8.1 PROGRESSIVE COMPANIES 264
11.8.2 RESPONSIVE COMPANIES 264
11.8.3 DYNAMIC COMPANIES 264
11.8.4 STARTING BLOCKS 264
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 266
11.8.5.1 Detailed list of key startups/SMEs 266
11.8.5.2 Competitive benchmarking of startups/SMEs 267
11.9 COMPETITIVE SCENARIO 268
11.9.1 PRODUCT LAUNCHES 268
11.9.2 DEALS 269
11.9.3 EXPANSIONS 270
11.9.4 OTHER DEVELOPMENTS 270
12 COMPANY PROFILES 271
12.1 KEY PLAYERS 271
12.1.1 THERMO FISHER SCIENTIFIC INC. 271
12.1.1.1 Business overview 271
12.1.1.2 Products offered 272
12.1.1.3 Recent developments 274
12.1.1.3.1 Product launches 274
12.1.1.3.2 Deals 274
12.1.1.3.3 Expansions 275
12.1.1.4 MnM view 276
12.1.1.4.1 Key strengths 276
12.1.1.4.2 Strategic choices 276
12.1.1.4.3 Weaknesses and competitive threats 276
12.1.2 MERCK KGAA 277
12.1.2.1 Business overview 277
12.1.2.2 Products offered 278
12.1.2.3 Recent developments 279
12.1.2.3.1 Deals 279
12.1.2.3.2 Expansions 280
12.1.2.4 MnM view 280
12.1.2.4.1 Key strengths 280
12.1.2.4.2 Strategic choices 280
12.1.2.4.3 Weaknesses and competitive threats 280
12.1.3 CORNING INCORPORATED 281
12.1.3.1 Business overview 281
12.1.3.2 Products offered 282
12.1.3.3 Recent developments 283
12.1.3.3.1 Product launches 283
12.1.3.4 MnM view 284
12.1.3.4.1 Key strengths 284
12.1.3.4.2 Strategic choices 284
12.1.3.4.3 Weaknesses and competitive threats 284
12.1.4 LONZA 285
12.1.4.1 Business overview 285
12.1.4.2 Products offered 286
12.1.4.3 Recent developments 287
12.1.4.3.1 Product launches 287
12.1.4.4 MnM view 287
12.1.4.4.1 Key strengths 287
12.1.4.4.2 Strategic choices 287
12.1.4.4.3 Weaknesses and competitive threats 287
12.1.5 AVANTOR, INC. 288
12.1.5.1 Business overview 288
12.1.5.2 Products offered 289
12.1.6 TECAN TRADING AG 290
12.1.6.1 Business overview 290
12.1.6.2 Products offered 291
12.1.6.3 MnM view 292
12.1.6.3.1 Key strengths 292
12.1.6.3.2 Strategic choices 292
12.1.6.3.3 Weaknesses and competitive threats 292
12.1.7 REPROCELL INC. 293
12.1.7.1 Business overview 293
12.1.7.2 Products offered 293
12.1.7.3 Recent developments 295
12.1.7.3.1 Deals 295
12.1.8 3D BIOTEK LLC 296
12.1.8.1 Business overview 296
12.1.8.2 Products offered 296
12.1.9 EMULATE, INC. 297
12.1.9.1 Business overview 297
12.1.9.2 Products offered 297
12.1.9.3 Recent developments 298
12.1.9.3.1 Product launches 298
12.1.10 SYNTHECON, INCORPORATED 299
12.1.10.1 Business overview 299
12.1.10.2 Products offered 299
12.1.11 INSPHERO 301
12.1.11.1 Business overview 301
12.1.11.2 Products offered 301
12.1.11.3 Recent developments 302
12.1.11.3.1 Deals 302
12.1.11.3.2 Other developments 302
12.1.12 KIRKSTALL LTD. 303
12.1.12.1 Business overview 303
12.1.12.2 Products offered 303
12.1.13 GREINER BIO-ONE INTERNATIONAL GMBH 304
12.1.13.1 Business overview 304
12.1.13.2 Products offered 304
12.1.14 PROMOCELL GMBH 305
12.1.14.1 Business overview 305
12.1.14.2 Products offered 305
12.1.15 UPM 306
12.1.15.1 Business overview 306
12.1.15.2 Products offered 306
12.2 OTHER PLAYERS 307
12.2.1 CN BIO INNOVATIONS LTD. 307
12.2.2 TISSUSE GMBH 308
12.2.3 LENA BIOSCIENCES 309
12.2.4 CELLENDES GMBH 310
12.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO) 311
12.2.6 SYNVIVO, INC. 312
12.2.7 AMS BIOTECHNOLOGY (EUROPE) LTD 313
12.2.8 MIMETAS B.V. 314
12.2.9 S-BIO, VAUPELL HOLDINGS INC. 315
12.2.10 NANOFIBER SOLUTIONS 315
13 APPENDIX 316
13.1 DISCUSSION GUIDE 316
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 319
13.3 CUSTOMIZATION OPTIONS 321
13.4 RELATED REPORTS 321
13.5 AUTHOR DETAILS 322
LIST OF TABLES
TABLE 1 3D CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS 33
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 45
TABLE 3 3D CELL CULTURE MARKET: RISK ANALYSIS 48
TABLE 4 3D CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 57
TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS 62
TABLE 6 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE 63
TABLE 7 IMPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND) 66
TABLE 8 IMPORT DATA FOR HS CODE 382100, 2020–2024 (TONS) 67
TABLE 9 EXPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND) 67
TABLE 10 EXPORT DATA FOR HS CODE 382100, 2020–2024 (TONS) 68
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 15 CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 76
TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 80
TABLE 17 3D CELL CULTURE PRODUCTS-RELATED TARIFF REVISION 81
TABLE 18 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS 83
TABLE 19 AVERAGE SELLING PRICE TREND OF 3D CELL CULTURE PRODUCTS,
BY KEY PLAYER, 2022–2024 (USD MILLION) 85
TABLE 20 AVERAGE SELLING PRICE TREND OF EQUIPMENT, BY REGION,
2022–2024 (USD MILLION) 88
TABLE 21 AVERAGE SELLING PRICE TREND OF KITS, BY REGION, 2022–2024 (USD MILLION) 88
TABLE 22 AVERAGE SELLING PRICE TREND OF REAGENTS, BY REGION,
2022–2024 (USD MILLION) 88
TABLE 23 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 91
TABLE 24 LIST OF KEY PATENTS IN 3D CELL CULTURE MARKET, 2023–2025 92
TABLE 25 3D CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS,
JANUARY 2025–DECEMBER 2026 93
TABLE 26 3D CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO
OF KEY PLAYERS, 2022−2025 94
TABLE 27 3D CELL CULTURE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 98
TABLE 28 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER 100
TABLE 29 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 104
TABLE 30 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 105
TABLE 31 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 32 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 33 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 34 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 35 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 36 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 37 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 38 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 39 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 40 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/
ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 41 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 42 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 43 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY REGION, 2023–2030 (USD MILLION) 110
TABLE 44 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 45 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS,
BY REGION, 2023–2030 (USD MILLION) 112
TABLE 46 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 47 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 48 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 49 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 50 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY REGION, 2023–2030 (USD MILLION) 114
TABLE 51 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 52 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 53 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 54 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 55 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 56 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 57 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 58 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 59 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 118
TABLE 60 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 61 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 62 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 63 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 64 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 65 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 66 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 67 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES,
BY REGION, 2023–2030 (USD MILLION) 122
TABLE 68 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 69 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 70 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 71 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 72 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 73 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 74 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES,
BY REGION, 2023–2030 (USD MILLION) 126
TABLE 75 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 76 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 77 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 78 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 79 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 80 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 81 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY REGION, 2023–2030 (USD MILLION) 129
TABLE 82 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 83 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS,
BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 84 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 85 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 86 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY REGION, 2023–2030 (USD MILLION) 131
TABLE 87 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 88 MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 89 NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 90 EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 91 ASIA PACIFIC: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 92 LATIN AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 93 MIDDLE EAST: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 94 GCC COUNTRIES: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 95 MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 96 NORTH AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 97 EUROPE: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 98 ASIA PACIFIC: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 99 LATIN AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 100 MIDDLE EAST: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY REGION, 2023–2030 (USD MILLION) 138
TABLE 101 GCC COUNTRIES: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 102 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140
TABLE 103 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 104 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 105 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 106 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 107 LATIN AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 108 MIDDLE EAST: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 109 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 110 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING,
BY REGION, 2023–2030 (USD MILLION) 144
TABLE 111 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 112 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 113 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 114 LATIN AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 115 MIDDLE EAST: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION) 146
TABLE 116 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 117 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 118 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 119 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 120 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 121 LATIN AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 122 MIDDLE EAST: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION) 150
TABLE 123 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 124 3D CELL CULTURE MARKET, BY MODEL TYPE, 2023–2030 (USD MILLION) 151
TABLE 125 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 153
TABLE 126 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 127 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 128 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 129 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 130 LATIN AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 131 MIDDLE EAST: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 156
TABLE 132 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 133 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 134 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 135 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 136 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 137 LATIN AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 138 MIDDLE EAST: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY REGION, 2023–2030 (USD MILLION) 160
TABLE 139 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 140 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION,
2023–2030 (USD MILLION) 161
TABLE 141 NORTH AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 142 EUROPE: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 143 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 144 LATIN AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 145 MIDDLE EAST: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY,
BY REGION, 2023–2030 (USD MILLION) 164
TABLE 146 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 147 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 165
TABLE 148 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 149 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 150 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 151 LATIN AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 152 MIDDLE EAST: 3D CELL CULTURE MARKET FOR OTHER END USERS,
BY REGION, 2023–2030 (USD MILLION) 167
TABLE 153 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 154 3D CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION) 169
TABLE 155 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 171
TABLE 156 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 157 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 158 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 159 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 173
TABLE 160 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 174
TABLE 161 US: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 162 US: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 163 US: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 164 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176
TABLE 165 US: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 176
TABLE 166 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 167 CANADA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 168 CANADA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 169 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 178
TABLE 170 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 178
TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180
TABLE 172 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 173 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 174 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 175 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 181
TABLE 176 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 182
TABLE 177 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 178 GERMANY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 179 GERMANY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 180 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 184
TABLE 181 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 184
TABLE 182 UK: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 183 UK: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 184 UK: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 185 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 186
TABLE 186 UK: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 187
TABLE 187 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 188 FRANCE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 189 FRANCE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 190 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 189
TABLE 191 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 189
TABLE 192 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 193 ITALY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 194 ITALY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 195 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 191
TABLE 196 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 192
TABLE 197 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 198 SPAIN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 199 SPAIN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 200 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 194
TABLE 201 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 194
TABLE 202 REST OF EUROPE: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 203 REST OF EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 204 REST OF EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 205 REST OF EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 196
TABLE 206 REST OF EUROPE: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 197
TABLE 207 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 199
TABLE 208 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 209 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 200
TABLE 210 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 200
TABLE 211 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 200
TABLE 212 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 201
TABLE 213 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 214 CHINA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 215 CHINA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 216 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 203
TABLE 217 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 204
TABLE 218 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 219 JAPAN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 220 JAPAN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 221 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 206
TABLE 222 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 206
TABLE 223 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 224 INDIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 225 INDIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 226 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 208
TABLE 227 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 209
TABLE 228 SOUTH KOREA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 229 SOUTH KOREA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 230 SOUTH KOREA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 231 SOUTH KOREA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 211
TABLE 232 SOUTH KOREA: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 212
TABLE 233 AUSTRALIA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 234 AUSTRALIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 235 AUSTRALIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 236 AUSTRALIA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 213
TABLE 237 AUSTRALIA: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 214
TABLE 238 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 239 REST OF ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 240 REST OF ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 241 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 216
TABLE 242 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 217
TABLE 243 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 218
TABLE 244 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 245 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 246 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 247 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 220
TABLE 248 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 221
TABLE 249 BRAZIL: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 250 BRAZIL: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 222
TABLE 251 BRAZIL: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 252 BRAZIL: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 223
TABLE 253 BRAZIL: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 223
TABLE 254 MEXICO: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 255 MEXICO: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 256 MEXICO: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 257 MEXICO: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 225
TABLE 258 MEXICO: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 226
TABLE 259 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 260 REST OF LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 261 REST OF LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 262 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 228
TABLE 263 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 229
TABLE 264 MIDDLE EAST: 3D CELL CULTURE MARKET, BY REGION,
2023–2030 (USD MILLION) 230
TABLE 265 MIDDLE EAST: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 266 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 231
TABLE 267 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 231
TABLE 268 MIDDLE EAST: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 232
TABLE 269 MIDDLE EAST: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 232
TABLE 270 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 233
TABLE 271 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 272 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 273 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 274 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 234
TABLE 275 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 235
TABLE 276 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 277 SAUDI ARABIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 278 SAUDI ARABIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 237
TABLE 279 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 237
TABLE 280 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 238
TABLE 281 UAE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 282 UAE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 283 UAE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 284 UAE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 240
TABLE 285 UAE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 240
TABLE 286 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 287 REST OF GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 288 REST OF GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 289 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 242
TABLE 290 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 243
TABLE 291 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 292 REST OF MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 293 REST OF MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 294 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 245
TABLE 295 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY END USER,
2023–2030 (USD MILLION) 246
TABLE 296 AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 297 AFRICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 298 AFRICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 299 AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 248
TABLE 300 AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 249
TABLE 301 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2022−SEPTEMBER 2025 251
TABLE 302 3D CELL CULTURE MARKET: DEGREE OF COMPETITION 255
TABLE 303 3D CELL CULTURE MARKET: REGION FOOTPRINT 261
TABLE 304 3D CELL CULTURE MARKET: PRODUCT FOOTPRINT 262
TABLE 305 3D CELL CULTURE MARKET: APPLICATION FOOTPRINT 262
TABLE 306 3D CELL CULTURE MARKET: END-USER FOOTPRINT 263
TABLE 307 3D CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 266
TABLE 308 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 267
TABLE 309 3D CELL CULTURE MARKET: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 268
TABLE 310 3D CELL CULTURE MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 269
TABLE 311 3D CELL CULTURE MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 270
TABLE 312 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–SEPTEMBER 2025 270
TABLE 313 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 271
TABLE 314 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 272
TABLE 315 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 274
TABLE 316 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 274
TABLE 317 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS,
JANUARY 2022–SEPTEMBER 2025 275
TABLE 318 MERCK KGAA: COMPANY OVERVIEW 277
TABLE 319 MERCK KGAA: PRODUCTS OFFERED 278
TABLE 320 MERCK KGAA: DEALS, JANUARY 2022–SEPTEMBER 2025 279
TABLE 321 MERCK KGAA: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 280
TABLE 322 CORNING INCORPORATED: COMPANY OVERVIEW 281
TABLE 323 CORNING INCORPORATED: PRODUCTS OFFERED 282
TABLE 324 CORNING INCORPORATED: PRODUCT LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 283
TABLE 325 LONZA: COMPANY OVERVIEW 285
TABLE 326 LONZA: PRODUCTS OFFERED 286
TABLE 327 LONZA: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 287
TABLE 328 AVANTOR, INC.: COMPANY OVERVIEW 288
TABLE 329 AVANTOR, INC.: PRODUCTS OFFERED 289
TABLE 330 TECAN TRADING AG: COMPANY OVERVIEW 290
TABLE 331 TECAN TRADING AG: PRODUCTS OFFERED 291
TABLE 332 REPROCELL INC.: COMPANY OVERVIEW 293
TABLE 333 REPROCELL INC.: PRODUCTS OFFERED 293
TABLE 334 REPROCELL INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 295
TABLE 335 3D BIOTEK LLC: COMPANY OVERVIEW 296
TABLE 336 3D BIOTEK LLC: PRODUCTS OFFERED 296
TABLE 337 EMULATE, INC.: COMPANY OVERVIEW 297
TABLE 338 EMULATE, INC.: PRODUCTS OFFERED 297
TABLE 339 EMULATE, INC.: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 298
TABLE 340 SYNTHECON, INCORPORATED: COMPANY OVERVIEW 299
TABLE 341 SYNTHECON, INCORPORATED: PRODUCTS OFFERED 299
TABLE 342 INSPHERO: COMPANY OVERVIEW 301
TABLE 343 INSPHERO: PRODUCTS OFFERED 301
TABLE 344 INSPHERO: DEALS, JANUARY 2022–SEPTEMBER 2025 302
TABLE 345 INSPHERO: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 302
TABLE 346 KIRKSTALL LTD.: COMPANY OVERVIEW 303
TABLE 347 KIRKSTALL LTD.: PRODUCTS OFFERED 303
TABLE 348 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW 304
TABLE 349 GREINER BIO-ONE INTERNATIONAL GMBH: PRODUCTS OFFERED 304
TABLE 350 PROMOCELL GMBH: COMPANY OVERVIEW 305
TABLE 351 PROMOCELL GMBH: PRODUCTS OFFERED 305
TABLE 352 UPM: COMPANY OVERVIEW 306
TABLE 353 UPM: PRODUCTS OFFERED 306
TABLE 354 CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW 307
TABLE 355 TISSUSE GMBH: COMPANY OVERVIEW 308
TABLE 356 LENA BIOSCIENCES: COMPANY OVERVIEW 309
TABLE 357 CELLENDES GMBH: COMPANY OVERVIEW 310
TABLE 358 ADVANCED BIOMATRIX, INC.: COMPANY OVERVIEW 311
TABLE 359 SYNVIVO, INC.: COMPANY OVERVIEW 312
TABLE 360 AMS BIOTECHNOLOGY (EUROPE) LTD: COMPANY OVERVIEW 313
TABLE 361 MIMETAS B.V.: COMPANY OVERVIEW 314
TABLE 362 S-BIO, VAUPELL HOLDINGS INC.: COMPANY OVERVIEW 315
TABLE 363 NANOFIBER SOLUTIONS: COMPANY OVERVIEW 315
LIST OF FIGURES
FIGURE 1 3D CELL CULTURE MARKET SEGMENTATION AND REGIONAL SCOPE 33
FIGURE 2 3D CELL CULTURE MARKET: RESEARCH DESIGN 36
FIGURE 3 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES
(SUPPLY- AND DEMAND-SIDE PARTICIPANTS) 38
FIGURE 4 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 39
FIGURE 5 3D CELL CULTURE MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2024 40
FIGURE 6 COMPANY REVENUE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC., 2024 41
FIGURE 7 3D CELL CULTURE MARKET: INSIGHTS FROM PRIMARY EXPERTS 42
FIGURE 8 3D CELL CULTURE SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 43
FIGURE 9 3D CELL CULTURE MARKET: CAGR PROJECTIONS 44
FIGURE 10 3D CELL CULTURE MARKET: DATA TRIANGULATION 46
FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 49
FIGURE 12 3D CELL CULTURE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 50
FIGURE 13 3D CELL CULTURE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50
FIGURE 14 HIGH FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING
TO DRIVE MARKET 52
FIGURE 15 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 56
FIGURE 16 3D CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 75
FIGURE 17 AI USE CASES 78
FIGURE 18 AVERAGE SELLING PRICE OF EQUIPMENT, BY KEY PLAYER, 2024 (USD) 86
FIGURE 19 AVERAGE SELLING PRICE OF KITS, BY KEY PLAYER, 2024 (USD) 87
FIGURE 20 AVERAGE SELLING PRICE OF REAGENTS, BY KEY PLAYER, 2024 (USD) 87
FIGURE 21 AVERAGE SELLING PRICE OF EQUIPMENT, BY REGION, 2024 (USD MILLION) 89
FIGURE 22 AVERAGE SELLING PRICE OF KITS, BY REGION, 2024 (USD MILLION) 89
FIGURE 23 AVERAGE SELLING PRICE OF REAGENTS, BY REGION, 2024 (USD MILLION) 90
FIGURE 24 3D CELL CULTURE MARKET: PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024 91
FIGURE 25 3D CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO,
2022–2025 (USD MILLION) 95
FIGURE 26 3D CELL CULTURE MARKET: VALUE CHAIN ANALYSIS 95
FIGURE 27 3D CELL CULTURE MARKET: ECOSYSTEM ANALYSIS 97
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
3D CELL CULTURE PRODUCTS 99
FIGURE 29 KEY BUYING CRITERIA, BY END USER 100
FIGURE 30 NEW REVENUE POCKETS FOR PLAYERS IN 3D CELL CULTURE MARKET 102
FIGURE 31 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT 171
FIGURE 32 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT 198
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN 3D CELL CULTURE MARKET,
2020−2024 (USD MILLION) 253
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN 3D CELL CULTURE MARKET, 2024 254
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 256
FIGURE 36 EV/EBITDA OF KEY VENDORS 257
FIGURE 37 3D CELL CULTURE MARKET: BRAND/PRODUCT COMPARISON 257
FIGURE 38 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 259
FIGURE 39 3D CELL CULTURE MARKET: COMPANY FOOTPRINT 260
FIGURE 40 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 265
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 272
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2024) 278
FIGURE 43 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 282
FIGURE 44 LONZA: COMPANY SNAPSHOT (2024) 286
FIGURE 45 AVANTOR, INC: COMPANY SNAPSHOT (2024) 289
FIGURE 46 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 291
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31